rosiglitazone has been researched along with B Virus Infection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nauwynck, HJ; Poelaert, KCK; Van Cleemput, J; Zhao, J | 1 |
Chang, Y; Chen, YL; Chuang, HC; Hsieh, WC; Lan, BS; Su, IJ | 1 |
2 other study(ies) available for rosiglitazone and B Virus Infection
Article | Year |
---|---|
CCL2 and CCL5 driven attraction of CD172a
Topics: Animals; Cell Movement; Chemokine CCL2; Chemokine CCL5; Fluorescent Antibody Technique; Herpesviridae Infections; Herpesvirus 1, Equid; Horse Diseases; Horses; Monocytes; Nasal Mucosa; Quinacrine; Receptors, Immunologic; Rosiglitazone; Thiazolidinediones | 2017 |
Efficacy of peroxisome proliferator activated receptor agonist in the treatment of virus-associated haemophagocytic syndrome in a rabbit model.
Topics: Administration, Oral; Animals; Callithrix; Cell Line; Dose-Response Relationship, Drug; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Hypoglycemic Agents; Lymphohistiocytosis, Hemophagocytic; PPAR gamma; Rabbits; Rosiglitazone; Simplexvirus; Thiazolidinediones; Treatment Outcome; Tumor Necrosis Factor-alpha; Viral Load; Virus Replication | 2010 |